Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhongchao (ZCMD) Other Accumulated Expenses (2018 - 2025)

Zhongchao (ZCMD) reported Other Accumulated Expenses of $164177.0 for Q4 2025, down 33.26% year-over-year from $246002.0 in Q4 2024, and down 33.26% on a QoQ basis from $246002.0 in Q4 2024.

Zhongchao (ZCMD) has 6 years of Other Accumulated Expenses data on file, last reported at $164177.0 in Q4 2025.

  • Quarterly Other Accumulated Expenses fell 33.26% year-over-year to $164177.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $164177.0 (down 33.26% YoY) and the FY2025 annual result came in at $164177.0, down 33.26% from the prior year.
  • Other Accumulated Expenses retreated to $164177.0 in Q4 2025 per ZCMD's latest filing, from $246002.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $246002.0 in Q4 2024 and bottomed at $95595.0 in Q4 2022.
  • The 4-year median for Other Accumulated Expenses is $149961.5 (2023), against an average of $160380.0.
  • The widest annual swing landed in 2024, when Other Accumulated Expenses surged 81.22%; it then tumbled 33.26% in 2025.
  • Tracing ZCMD's Other Accumulated Expenses over 4 years: stood at $95595.0 in 2022, then jumped by 42.0% to $135746.0 in 2023, then surged by 81.22% to $246002.0 in 2024, then slumped by 33.26% to $164177.0 in 2025.
  • Per Business Quant, the three latest ZCMD Other Accumulated Expenses figures stand at $164177.0 (Q4 2025), $246002.0 (Q4 2024), and $135746.0 (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 Zhongchao - - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 164,177.00
Dec 31, 2024 246,002.00
Dec 31, 2023 135,746.00
Dec 31, 2022 95,595.00
Dec 31, 2019 51,720.00
Dec 31, 2018 29,925.00